Focus:
News
-
27 March 2020
VERO Biotech uses expanded access emergency for iNO delivery system
VERO Biotech has received ‘expanded access emergency use’ from the US Food and Drug Administration (FDA) for GENOSYL DS, its inhaled nitric oxide (iNO) delivery system.
-
27 March 2020
ExThera blood filter used to treat Covid-19
Hospitals in Germany and Italy have begun using ExThera’s Seraph 100 Microbind Affinity Blood Filter to treat Covid-19.
-
27 March 2020
Seqster releases Covid-19 Compass for healthcare enterprises
Software as a service (SaaS)-based technology platform Seqster has launched Covid-19 Compass into its interoperability platform amid the growing coronavirus (Covid-19) outbreak across the world.
-
27 March 2020
CardioQuip wins CE Mark approval for cooler-heaters to fight Covid-19
CardioQuip has received CE Mark approval for the MCH-1000 Modular Cooler-Heater Series, which is now available to the European healthcare systems, dealing with the coronavirus (Covid-19) pandemic.
-
26 March 2020
Astrotech develops screening instrument to detect Covid-19 infections
Astrotech is developing BreathTest-1000 to screen for volatile organic compound (VOC) metabolites that indicate infectious diseases, including coronavirus (Covid-19) or the resulting disease, pneumonia.
-
26 March 2020
Quidel gets expanded emergency use authorisation for SARS-CoV-2 test
The US Food and Drug Administration (FDA) has granted expanded emergency use authorisation (EUA) for Quidel’s Lyra SARS-CoV-2 Assay for the coronavirus (Covid-19) diagnosis.
-
26 March 2020
Medopad offers Covid-specific remote patient monitoring
British healthtech company Medopad is offering support to the global healthcare sector by providing clinicians with a specialised Covid-19 version of its remote patient monitoring (RPM) platform. The technology will...
-
26 March 2020
ixlayer adapts Covid-19 clinical testing platform
ixlayer has adapted its platform to help laboratories and healthcare systems to address the demand for rapid and increased coronavirus (Covid-19) clinical testing.
-
25 March 2020
Covid-19 test being designed to provide diagnosis in 30 minutes
Biopharmaceutical company Heat Biologics is collaborating with the University of Miami to develop a Covid-19 point-of-care diagnostic kit.
-
24 March 2020
AliveCor’s KardiaMobile 6L wins approval for use in Covid-19 patients
AliveCor’s KardiaMobile 6L technology has received the US Food and Drug Administration (FDA) approval to measure QTc and detection of potentially dangerous QT prolongation in coronavirus (Covid-19) patients.